Ovarian%20mass Treatment

Treatment

Pharmacotherapy

Combination Oral Contraceptives (OCs)

Combination OCs do not provide an advantage in the treatment of functional ovarian cysts when compared with expectant management
- Studies suggested that expectant management is as effective as hormonal treatment for the resolution of functional ovarian cysts
Patients may be offered OCs if they are seeking contraception
Estrogen/progestogen therapy may be useful in patients with anovulatory cycles who need OCs to induce the next period
Many combination OCs are available. Please see the latest MIMS for specific prescribing information

Gangliosides and cognition: An appraisal of the evidence

01 Sep 2018

Gangliosides and docosahexaenoic acid (DHA) play critical roles in early childhood brain development.

The changing treatment landscape for premenopausal women with advanced breast cancer: Focus on ribociclib

Dr. Wong Seng Weng, Dr. Lee Guek Eng, 19 Mar 2021

In Singapore, advanced breast cancer (aBC) is the leading cause of cancer death in women 30–49 years of age. For premenopausal women diagnosed with hormone receptor (HR)-positive, HER2-negative BC, cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors provide new hope. Currently, ribociclib is the only CDK4/6 inhibitor studied in the first-line setting for premenopausal women with HR+/HER2- aBC, in the phase III MONALEESA-7 trial. Two experts, Dr Wong Seng Weng, Medical Director & Consultant Medical Oncologist at The Cancer Centre, Paragon Medical & Mount Elizabeth Novena Specialist Centre, and Dr Lee Guek Eng, Senior Consultant & Specialist in Medical Oncology at Icon Cancer Centre and Program Director of the Young Women Cancer Program, weigh in with their views on managing premenopausal women with aBC.

Expert consensus: Patient profile should guide antihistamine choice in primary care setting

10 Dec 2019

Oral H₁-antihistamines are the initial treatment of choice for allergic rhinitis (AR) and chronic urticaria in the primary care setting. However, in a diverse population of patients with AR and urticaria, primary care physicians are faced with the challenge of prescribing the best therapy amid a wide armamentarium of antihistamines available.